Maravai Lifesciences Holdings (MRVI) Short term Debt (2020 - 2026)

Maravai Lifesciences Holdings' Short term Debt history runs 7 years deep, the most recent figure standing at $5.4 million for Q1 2026.

• In Q1 2026, Short term Debt changed 0.0% year-over-year to $5.4 million; the TTM figure through Mar 2026 stood at $5.4 million (changed 0.0% YoY), while the FY2025 annual figure was $5.4 million, changed 0.0% from the prior year.
• Short term Debt was $5.4 million for Q1 2026 at Maravai Lifesciences Holdings, roughly flat from $5.4 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $42.3 million in Q1 2023 to a low of $5.4 million in Q2 2022.
• Historically, Short term Debt has averaged $11.1 million across 5 years, with a median of $5.4 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Short term Debt soared 2576.96% in 2022, then sank 87.13% in 2024.
• A 5-year view of Short term Debt shows it stood at $5.4 million in 2022, then changed by 0.0% to $5.4 million in 2023, then changed by 0.0% to $5.4 million in 2024, then changed by 0.0% to $5.4 million in 2025, then changed by 0.0% to $5.4 million in 2026.
• The last three Short term Debt figures came in at $5.4 million (Q1 2026), $5.4 million (Q4 2025), and $5.4 million (Q3 2025), per Business Quant data.